Skip to main content

Closed

VNDA: Vanda Pharmaceuticals Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-73.6%

ROIC-52.8%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage0.0×

Current ratio2.16×

Vanda Pharmaceuticals Inc.

VNDANASDAQ Global Market·USD·Closed

Vanda Pharmaceuticals Inc.

VNDANASDAQ·USD·Closed

$5.10

−1.54%

$5.10

−$0.08 (1.54%)

52W Range

17thpctl

Volume

0.55×avg

Mkt Cap

306.69MUSD

P/E

-1.3TTM

Div Yield

–ann

52W Range

17thpctl

Volume

0.55×avg

Market Cap

306.69MUSD

P/E Ratio

-1.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings